Tools

LEADER 03368nam a22005658i 4500

001 ssj0002825162;

003 WaSeSS;

005 20251212090320.0;

006 m d ;

007 cr n ;

008 221219s2023 flu sb 001 0 eng d;

010 a| 2022057101;

020 a| 9781032432960q| (hardback);

020 a| 9781032431987q| (paperback);

020 z| 9781003366676q| (ebook);

035 a| (WaSeSS)ssj0002825162;

042 a| pcc;

049 a| EREEa| NEHH;

050 00 a| HF5439.D75;

060 00 a| QT 110;

082 00 a| 615.1068/82| 23/eng/20230429;

100 1 a| Qiu, Tingting.?| UNAUTHORIZED;

245 10 a| Regenerative medicineh| [electronic resource] :b| unlocking patient access and commercial potential /c| authored by Tingting Qiu, Mondher Toumi.;

250 a| First edition.;

260 a| Boca Raton :b| CRC Press,c| 2023.;

263 a| 2305;

300 a| pages cm;

490 1 a| Pharmaceuticals, health economics and market access series;

504 a| Includes bibliographical references and index.;

505 0 a| Regulation of RMs in the global -- Health technology assessment of RMs -- Challenges for market access of RMs -- Impact of COVID-19 on the RMs industry -- Partnerships to expediate successful market access of RMs -- Business models and commercial considerations for gene and cell therapies -- Summary of recommendation and perspective for future research.;

506 a| Available only to authorized users.;

520 a| "A comprehensive review of the challenges that exist in patient accessibility to advanced therapy medicinal products (ATMPs), presenting clinical trials, marketing authorization, HTA, pricing, reimbursement, affordability, payment and partnership agreements of RMs and commercialisation. Specfically, we investigated how COVID-19 has impacted the RMs industry by elaborating on the disruptions it caused but also the new opportunities it brought. The ultimate goal of this work is to make strategic recommendations for manufacturers and decisions-markers on effective strategies to address the above obstacles and facilitate patient access to promising regenerative medicines"--c| Provided by publisher.;

538 a| Mode of access: World Wide Web;

650 12 a| Regenerative Medicine=| ^A1012989;

650 22 a| Marketingx| methods=| ^A937799;

650 22 a| Biological Therapyx| economics=| ^A937857;

650 22 a| Biological Productsx| therapeutic use=| ^A921434;

655 0 a| Electronic books.=| ^A491897;

700 1 a| Toumi, Mondher.?| UNAUTHORIZED;

830 0 a| Pharmaceuticals, health economics and market access.?| UNAUTHORIZED;

856 40 z| Full text available from Taylor & Francis eBooksu| https://go.openathens.net/redirector/ecu.edu?url=https%3A%2F%2Fwww.taylorfrancis.com%2Fbooks%2F9781003366676;

949 a| CLICK ON WEB ADDRESSw| ASISh| JOYNER188;

949 a| CLICK ON WEB ADDRESSw| ASISh| HSL77;

949 a| CLICK ON WEB ADDRESSw| ASISh| JMUSIC60;

596 a| 1 3 4;

998 a| 6683314;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 6683314-1001l| JNETm| JOYNERr| Ys| Yt| JNESSBKu| 12/19/2025x| EBOOKz| JERESOURCE;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 6683314-2001l| HSLELECm| HSLr| Ys| Yt| HEBKu| 12/19/2025x| EBOOKz| HERESOURCE;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 6683314-3001l| MNETm| JMUSICr| Ys| Yt| MNESSBKu| 12/19/2025x| EBOOKz| JERESOURCE;

Regenerative medicine unlocking patient access and commercial potential / authored by Tingting Qiu, Mondher Toumi.

Author/creator	Qiu, Tingting
Other author	Toumi, Mondher.
Format	Electronic
Edition	First edition.
Publication Info	Boca Raton : CRC Press, 2023.
Description	pages cm
Supplemental Content	Full text available from Taylor & Francis eBooks
Subjects	Regenerative Medicine Marketing--methods. Biological Therapy--economics. Biological Products--therapeutic use.

Series	Pharmaceuticals, health economics and market access series Pharmaceuticals, health economics and market access. UNAUTHORIZED
Contents	Regulation of RMs in the global -- Health technology assessment of RMs -- Challenges for market access of RMs -- Impact of COVID-19 on the RMs industry -- Partnerships to expediate successful market access of RMs -- Business models and commercial considerations for gene and cell therapies -- Summary of recommendation and perspective for future research.
Abstract	"A comprehensive review of the challenges that exist in patient accessibility to advanced therapy medicinal products (ATMPs), presenting clinical trials, marketing authorization, HTA, pricing, reimbursement, affordability, payment and partnership agreements of RMs and commercialisation. Specfically, we investigated how COVID-19 has impacted the RMs industry by elaborating on the disruptions it caused but also the new opportunities it brought. The ultimate goal of this work is to make strategic recommendations for manufacturers and decisions-markers on effective strategies to address the above obstacles and facilitate patient access to promising regenerative medicines"-- Provided by publisher.
Bibliography note	Includes bibliographical references and index.
Access restriction	Available only to authorized users.
Technical details	Mode of access: World Wide Web
Genre/form	Electronic books.
LCCN	2022057101
ISBN	9781032432960 (hardback)
ISBN	9781032431987 (paperback)
ISBN	(ebook)

Availability

Library	Location	Call Number	Status	Item Actions
	Electronic Resources	Access Content Online	✔ Available

Regenerative medicine unlocking patient access and commercial potential / authored by Tingting Qiu, Mondher Toumi.

Click here for more information about this title

Availability